Lesson plan
ECHO-7
ECHO-7 (trade name Rigvir) is a wild type member of the echovirus group of viruses. It was formerly approved as a virotherapy medication by the State Agency of Medicines of the Republic of Latvia (2004–19). In March 2019, laboratory tests found the medicine to contain far smaller quantities of ECHO-7 virus than its manufacturer claimed. On May 31, 2019, the State Agency of Medicines suspended the registration licence of ECHO-7.
Article summary
ECHO-7 (trade name Rigvir) is a wild type member of the echovirus group of viruses. It was formerly approved as a virotherapy medication by the State Agency of Medicines of the Republic of Latvia (2004–19). In March 2019, laboratory tests found the medicine to contain far smaller quantities of ECHO-7 virus than its manufacturer claimed. On May 31, 2019, the State Agency of Medicines suspended the registration licence of ECHO-7.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.